Clinical trial
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
NCT00081458 · Shire, Industry · Completed
Key facts
| NCT number | NCT00081458 |
|---|---|
| Title | Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome |
| Official title | A Study of the Efficacy and Safety of Teduglutide in Subjects With Parenteral Nutrition-Dependent Short Bowel Syndrome |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Short Bowel Syndrome |
| Intervention type | Drug |
| Interventions | Placebo, Teduglutide 0.05 mg/kg/d, Teduglutide 0.1 mg/kg/d |
| Enrollment | 84 |
| Start date | May 25, 2004 |
| Primary completion | Jul 6, 2007 |
| Completion | Jul 6, 2007 |
| First posted | Apr 14, 2004 |
| Last update posted | Jun 9, 2021 |
| Countries | Belgium, Canada, Denmark, France, Germany, Netherlands, Poland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: